Replies to post #11388 on Seelos Therapeutics Inc (SEEL)

[carlodb1978]

We expect to announce one or more additional Vitaros(R) partnerships this quarter and anticipate the rollout of multiple Vitaros(R) launches across Europe in 2014."

[nbm16yankees]

Good news but I am not clear....
Please explain to me what they mean...

The Company has now received a total of six national phase approvals for Vitaros(R), including Germany, Ireland, Italy, the Netherlands, Sweden and the United Kingdom ("UK") following its broad approval by European health authorities in June 2013.


The Company continues to work toward obtaining country-by-country national phase approvals in the remaining CMS territories including France, Spain, Belgium and Luxembourg. Once the national phase approvals are secured on a country-by-country basis, marketing of Vitaros® can then be initiated in each country by Apricus' commercialization partners.

They have Broad approval,but still waiting for phase approval in certain countries.
Are they planning on waiting until all phase approvals are obtained, before they launch anywhere?
If not, why havent they launched in any of the countries that have phase approval?
And why did they make such a big deal out of the French partnership, if the phase approval has not been received? Seems to me with the countries already "phase approved" they should have launched somewhere by now.